UnitedHealth Group Incorporated (NYSE:UNH) shares sold by Pathway Financial Advisors LLC

Pathway Financial Advisors LLC lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 18.0% during the 3rd quarter, HoldingsChannel reports. The firm owned 1,092 shares of the medical conglomerate’s stock after selling 239 shares during the quarter. Pathway Financial Advisors LLC’s holdings in UnitedHealth Group were worth $638,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Rockingstone Advisors LLC purchased a new position in shares of UnitedHealth Group in the third quarter valued at approximately $291,000. Hoxton Planning & Management LLC raised its holdings in UnitedHealth Group by 30.8% in the third quarter. Hoxton Planning & Management LLC now owns 1,512 shares of the medical conglomerate’s stock valued at $884,000 after acquiring an additional 356 shares during the last quarter. Brookstone Capital Management boosted its holdings in UnitedHealth Group by 6.7% in the third quarter. Brookstone Capital Management now owns 24,289 shares of the medical conglomerate’s stock valued at $14,201,000 after purchasing an additional 1,529 shares during the last quarter. Sugarloaf Wealth Management LLC boosted its holdings in UnitedHealth Group by 1.3% in the third quarter. Sugarloaf Wealth Management LLC now owns 6,764 shares of the healthcare conglomerate’s stock valued at $3,955,000 after acquiring an additional 90 shares during the last quarter. Finally, Park Place Capital Corp boosted its holdings in UnitedHealth Group by 4.2% in the third quarter. Park Place Capital Corp now owns 4,428 shares of the medical conglomerate’s stock valued at $2,589,000 after acquiring an additional 177 shares during the last quarter. 87.86% of the shares are currently owned by institutional investors and hedge funds.

Insider trading at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the sale, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. This represents a 0.00 % decrease in ownership of the shares. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible via this link. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. This trade represents a decrease of 0.00 % in the stock holding. The sale was disclosed in a filing with the SEC, which is accessible through the SEC’s website. Also, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. This trade represents a decrease of 0.00 % in the stock holding. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s shares.

UnitedHealth Group’s stock performance

NYSE:UNH opened at $581.56 on Wednesday. The company’s fifty day moving average price is $582.58 and its 200 day moving average price is $528.49. The firm has a market cap of $537.02 billion, a PE ratio of 35.55, a price-to-earnings-growth ratio of 1.65 and a beta of 0.58. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $607.94. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88, and a quick ratio of 0.88.

UnitedHealth Group (NYSE:UNH – Get Free Report ) last issued its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.66 by $0.14. The company had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The company’s quarterly revenue was up 6.4% compared to the same quarter last year. In the same quarter last year, the company posted earnings of $6.14 per share. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group announces dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, September 16th. This represents an annualized dividend of $8.40 and a dividend yield of 1.44%. UnitedHealth Group’s dividend payout ratio (DPR) is 51.34%.

Analyst upgrades and downgrades

A number of research analysts recently commented on UNH shares. Barclays upped their price objective on UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. Cantor Fitzgerald restated an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a research note on Tuesday, October 1st. HSBC boosted their price target on UnitedHealth Group from $580.00 to $610.00 in a research note on Thursday, July 18th. Jefferies Financial Group upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and upped their target price for the stock from $481.00 to $647.00 in a research note on Wednesday. July 17. Finally, Morgan Stanley boosted their price objective on UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Two investment analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $614.17.

Check out our latest analysis of UnitedHealth Group

UnitedHealth Group Company Profile

(Free report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight and Optum Rx. The UnitedHealthcare segment provides consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses and individuals; health care coverage and health and wellness services for people age 50 and older that address their needs; Medicaid plans, children’s health insurance and health care programs; and health and dental benefits and hospital and clinic services, and health care products and services for state care programs for the economically disadvantaged, medically underserved, and those without funded health care coverage by employer.

Read more

Want to see what other hedge funds own UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).

Get daily news and ratings for UnitedHealth Group – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.